Endo International Files for Bankruptcy to Weather Opioid Lawsuits

Endo International PLC became the latest pharmaceutical company to file for bankruptcy under the weight of lawsuits alleging it played a role in fueling the opioid crisis. The drugmaker, domiciled in ...

More Shoppers Buy Store Brands, Eating Into Big Food Companies’ Sales

Cost-conscious consumers are buying more store brands at the supermarket, raising pressure on big food companies that are dealing with their own rising costs. Lower-cost oatmeal, pickles, granola bars...

Bed Bath & Beyond Followed a Winning Playbook—and Lost

Mark Tritton arrived at Bed Bath & Beyond in 2019 with a plan to revive the home-goods retailer and ward off competition from Amazon.com Inc., Target Corp. and other large chains: sell what nobody...

Buying From Mark Cuban’s Pharmacy Could Save Medicare Billions, Study Says

Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cuban, according to...

Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver

Viatris Inc. said Monday it has agreed to combine its biosimilars portfolio with privately held Indian company Biocon Biologics Ltd. for up to $3.335 billion, as part of a broader overhaul of its busi...

Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.

Viatris will sell the biosimilars business of the former Mylan to the Indian drugmaker Biocon for as much as $3.3 billion. Dreamstime Text size Viatris , the company formed in 2020 through a merger of...